Search   
MSDS  : D-chiro-Inositol, 1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxyme thyl)-1-((4,5,6- trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino) -, (1S-(1-alpha,4-alpha,5-beta, 6-alpha))-
CAS  : 37248-47-8
SYNONYMS  : * T-7545-A * Validacin * Validamycin A * Valimon
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : NM7540000
CHEMICAL NAME : D-chiro-Inositol,
1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxyme
thyl)-1-((4,5,6-
trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)
-, (1S-(1-alpha,4-alpha,5-beta, 6-alpha))-
CAS REGISTRY NUMBER : 37248-47-8
LAST UPDATED : 199606
DATA ITEMS CITED : 11
MOLECULAR FORMULA : C20-H35-N-O13
MOLECULAR WEIGHT : 497.56
COMPOUND DESCRIPTOR : Agricultural Chemical
Drug
Mutagen
Natural Product
SYNONYMS/TRADE NAMES :
* T-7545-A
* Validacin
* Validamycin A
* Valimon

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >20 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPIFAN Japan Pesticide Information. (Japan Plant Protection Assoc.,
1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) No.1-61, 1969-92. For
publisher information, see AGJAEP. Volume(issue)/page/year: (15),28,1973

TYPE OF TEST : LC50 - Lethal concentration, 50 percent kill
ROUTE OF EXPOSURE : Inhalation
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >5 gm/m3
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NNGADV Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of
Japan. (Nippon Noyaku Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170,
Japan) V.1- 1976- Volume(issue)/page/year: 17,S29,1992

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Administration onto the skin
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPIFAN Japan Pesticide Information. (Japan Plant Protection Assoc.,
1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) No.1-61, 1969-92. For
publisher information, see AGJAEP. Volume(issue)/page/year: (40),32,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPIFAN Japan Pesticide Information. (Japan Plant Protection Assoc.,
1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) No.1-61, 1969-92. For
publisher information, see AGJAEP. Volume(issue)/page/year: (47),17,1985

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >15 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPIFAN Japan Pesticide Information. (Japan Plant Protection Assoc.,
1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) No.1-61, 1969-92. For
publisher information, see AGJAEP. Volume(issue)/page/year: (47),17,1985

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 7200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPIFAN Japan Pesticide Information. (Japan Plant Protection Assoc.,
1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) No.1-61, 1969-92. For
publisher information, see AGJAEP. Volume(issue)/page/year: (47),17,1985

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
85GDA2 "CRC Handbook of Antibiotic Compounds," Vols.1- , Berdy, J., Boca
Raton, FL, CRC Press, 1980- Volume(issue)/page/year: 1,229,1980

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 13 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPIFAN Japan Pesticide Information. (Japan Plant Protection Assoc.,
1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) No.1-61, 1969-92. For
publisher information, see AGJAEP. Volume(issue)/page/year: (47),17,1985

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >15 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPIFAN Japan Pesticide Information. (Japan Plant Protection Assoc.,
1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) No.1-61, 1969-92. For
publisher information, see AGJAEP. Volume(issue)/page/year: (47),17,1985

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >13 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPIFAN Japan Pesticide Information. (Japan Plant Protection Assoc.,
1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) No.1-61, 1969-92. For
publisher information, see AGJAEP. Volume(issue)/page/year: (15),28,1973

*** STATUS IN U.S. ***

EPA GENETOX PROGRAM 1988, Negative: B subtilis rec assay


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
D-myo-Inositol,O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2, 6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-3-amino-2,3- dideoxy- 91421-97-5
D-myo-Inositol,O-2,3-diamino-dideoxy-alpha-D-gucopyranosyl-(1-1)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl(1-3)-2,4-diamino-6-((4-amino-2-hy droxy-1-oxobutyl)amino)-2,4,5,6-tetradeoxy-, (S)- 161822-04-4
D-myo-Inositol,O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-1,3-diamino-1,3-dideoxy- 52248-05-2
epi-Inositol,2,3-dideoxy-2-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-4-C-(hydroxymethyl )- 112653-29-9
D-chiro-Inositol,1,5-dideoxy-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2- cyclohexen-1-yl)amino)-,(1S-(1-alpha,4-alpha,5-beta,6-alpha))- 39318-73-5
2-Indolinone,3-(3-dimethylaminopropyl)-1-methyl-3-phenyl-,hydrochloride 10565-90-9
D-chiro-Inositol,O-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranosyl-(1-3)-1,5,6-trideoxy-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cycloh exen-1-yl)amino)-,(1S-(1-alpha,4-alpha,5-beta,6-alpha))- 12650-71-4
Inositol,hexakis(2-(p-chlorophenoxy)-2-methylpropionate), myo- 14496-74-3
Inositol, hexakis(dihydrogen phosphate), myo- 83-86-3
Inositol, hexakis(dihydrogen phosphate), calciummagnesium salt, myo- 3615-82-5
Inositol, hexakis(dihydrogen phosphate) sodium salt,myo- 14306-25-3
Inositol, hexakis(disodium phosphate), hydrate (135) 14306-25-3
myo-Inositol, hexakis(5-fluoro-3-pyridinecarboxylate) 23763-98-6
myo-Inositol, hexakis(hydrogen sulfate), hexasodiumsalt 70701-62-1
Inositol, hexanicotinate, myo- 6556-11-2
meso-Inositol, hexanitrate 6556-11-2
2-Indolinone, 3,3-bis(2-hydroxypropyl)-1-phenyl- 20870-64-8
2-Indolinone,3-(3-(dimethylamino)propyl)-1-(methyl-2-thenylamino)-3-phenyl- 33391-50-3
scyllo-Inositol, hexanitrate 33391-50-3
D-chiro-Inositol,5-(hydroxymethyl)-1,5,6-trideoxy-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2- cyclohexen-1-yl)amino)-,(1S-(1-alpha,4-alpha,5-beta,6-alpha))- 38665-10-0
D-chiro-Inositol,1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-, (1S-(1-alpha,4-alpha,5-beta, 6-alpha))- 37248-47-8
InstanetSUBSTANCE DEFINITION :Consists of butylglycol and a small quantity of ethanolREFERENCE :HUTODJ Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke,Hants., RG 21 2XS, UK) V.1- 1981- Volume(issue)/page/year: 8,243,1989 37248-47-8
Insularinium, 2,2'-dimethyl-, diiodide 32434-10-9
Insulin 9004-10-8
Insulin, pyrolyzate 9004-10-8
Insulin (dog) 12584-58-6
Insulin (human), 28b-L-lysine-29b-L-proline- 133107-64-9
Insulin-like growth factor I 67763-96-6
2-Indolinone,1,5-dimethyl-3-(5-phenyl-1,3,4-oxadiazol-2-ylimino)- 84640-78-8
Insulin-like growth factor I (human) 68562-41-4
Insulin-like growth factor II 67763-97-7
Insulin protamine zinc 9004-17-5
Insulin sensitizer enhancer, S18277 9004-17-5
Insulin zinc 8049-62-5
Integerrimine 480-79-5
Interferon-alpha 480-79-5
Interferon-alpha-2 (human leucocyte clone pM21protein moiety reduced) 98530-12-2
Interferon-alpha-2 (human leucocyte protein moietyreduced) 75432-97-2
Interferon-alpha-4 (human leucocyte) 75432-97-2
2-Indolinone,3,3-diphenyl-5-methoxy-1-(piperidinomethyl)- 81252-99-5
Interferon-beta, (human)SUBSTANCE DEFINITION :A polypeptide consisting of 166 amino acidsREFERENCE :KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, KandaSuda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- 81252-99-5
Interferon A (human myeloblastoid KG-1 protein moietyreduced) 76543-88-9
Interferon-gamma (human lymphocyte protein moietyreduced) 82115-62-6
Interferon-gamma, OH-6000 82115-62-6
Interferons 9008-11-1
Interleukin 1SUBSTANCE DEFINITION :Purified interleukin 1 derived from human monocytesREFERENCE :CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & ChestnutSts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:47,5612,1987 9008-11-1
Interleukin-1-alpha 9008-11-1
Interleukin-1-beta 9008-11-1
Interleukin 2 (human clone pTG853 protein moietyreduced) 94218-75-4
Interleukin 2 (human clone pTIL2-21a protein moiety) 94218-72-1

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net